Trials for coronavirus vaccine could start next month in the UK

The vaccine was developed by pharmaceutical company Can Sino Biologics in cooperation with the Chinese military

The vaccine was developed by pharmaceutical company Can Sino Biologics in cooperation with the Chinese military

The U.K. government will fund the six new projects, including others developing antibodies to help target the virus, examining how people at the highest risk could be identified, and how existing treatments can be used for the treatment of the coronavirus disease (COVID-19).

If human trials move on successfully, the researchers at Oxford University will begin a larger trial to assess the effectiveness of the vaccine.

It uses the same technique as a vaccine the team previously developed for the closely-related Middle East Respiratory Syndrome (Mers) coronavirus, which showed promise in animal and early-stage human testing.

The first round of projects will receive £10.5 million and are being launched by researchers at a range of universities, including Belfast, Oxford, Liverpool, and Imperial College London, as well Chelsea and Westminster Hospital, Imperial College. This means the pathogen is less likely to become more unsafe as it spreads, giving researchers hope that they could create a long-lasting vaccine for the deadly virus that has killed over 18,500 people across the globe in a matter of few months.

The Chinese attempt started on March 16-the same day as the United States declaration-and is predicted to continue until the year-end, in response to a filing in the nation's Clinical Trial Registry, dated March 17.

Tsunami warnings after magnitude 7.8 quake strikes near Russia's Kuril islands
Geological Survey said the quake struck 219 kilometres south-southeast of Severo on the Kuril chain north of Japan. National Tsunami Warning Center that said the agency is working to determine the threat.

UK Research and Innovation Chief Executive, Professor Sir Mark Walport said: "These studies will be critical to finding better ways to treat and manage COVID-19, which we hope will help to save lives, protect the more vulnerable, and support the development, trials and in due course the scale up of production of much-needed vaccines. This investment will speed up globally-recognized vaccine development capabilities and help us find a new defense against this disease", Matt Hancock, Health Secretary, said. They are working with Chinese scientists to develop antibody therapy to kill the virus. The drugs will be tested to see if they are safe and effective when added to the usual standard of care. The trials use an adaptive design, which means it can test new treatments as they become available.

The project, led by Prof Peter Horby of the University of Oxford, will first test two HIV drug therapies: lopinavir-ritonavir and low-dose corticosteroids.

Another project includes one that will review the disease and how it affects different patients.

Another funded project is seeking to collect data on NHS coronavirus patients to answer many urgent questions - including which treatments worked best, how the disease was transmitted and why are some people at higher risk of severe illness - to better inform efforts to control the outbreak and improve treatment for patients in real time.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.